The approval was based on positive results observed in the ATTRibute-CM Phase 3 study, where Attruby demonstrated a ...

Mizuho Securities analyst Salim Syed has assigned their bullish stance on BBIO stock, giving a Buy rating on November 25.Don't Miss our Black ...

Analyst Mani Foroohar from Leerink Partners maintained a Buy rating on BridgeBio Pharma (BBIO – Research Report) and increased the price target to $47.00 from $46.00. Don't Miss our Black Friday ...

Real-time Data is provided using Nasdaq Last Sale Data Data provided by Nasdaq Data Link, a premier source for financial, economic and alternative datasets. Data Link's cloud-based technology ...

We project BridgeBio's key drug candidate, Attruby (acoramidis), could achieve global sales of around $3.3 billion by 2033. Attruby is an oral drug designed to treat transthyretin amyloid ...

The U.S. Department of Agriculture’s Food Safety and Inspection Service (FSIS) is issuing a public health alert for beef tallow products that were illegally imported from Mexico and are ...

After hours: November 25 at 4:51 PM EST Loading Chart for SNY ...

After hours: November 22 at 4:48 PM EST Loading Chart for CHDN ...

After hours: November 22 at 7:09 PM EST Loading Chart for ZI ...

After hours: November 22 at 4:08 PM EST Loading Chart for TIL ...

Netflix announced in April 2024 that it had officially ordered and put into production a new action thriller called Ad Vitam, which translates to To Life in English. The movie has since completed ...